Cancer is associated with a complex thrombophilic state driven by specific pathogenetic mechanisms and clinical risk factors that predispose patients to thromboembolism.
This review summarizes the biology, incidence, and risk factors for thromboembolism in patients with cancer.
Absolute Event Rate: 0% vs 0%
The association between malignancy and thrombosis has long been appreciated but remains incompletely understood. This is the first of a two-part review of the complex, integral relationship between these two entities, and addresses the mechanisms and pathogenesis of this relationship and the clinical risk factors for thromboembolism in cancer patients.
DiPasco et al. (Thu,) reported a other. Cancer is associated with a complex thrombophilic state driven by specific pathogenetic mechanisms and clinical risk factors that predispose patients to thromboembolism.